Stephanie Krebs - 01 Nov 2023 Form 3 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role: Chief Business Officer
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol: SNSE
Transactions as of: 01 Nov 2023
Transactions value $: $0
Form type: 3
Date filed: 02 Nov 2023, 16:50
Next filing: 23 Dec 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney